Bile Duct Cancer Drug Market - Global Industry Analysis
Bile Duct Cancer Drug Market by Type (5-fluorouracil (5-FU), Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, and Others) and by Application (Hospitals, Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024
Published Date: 07-Jan-2019Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-3702
Status : Published
Global bile duct cancer drug market expected to generate revenue of around USD 262 million by 2024, at a CAGR of around 6.6% between 2018 and 2024. The major growth driver of the global bile duct cancer drug market is the increase in the prevalence of bile duct cancer patients across the globe.